{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:44:50Z","timestamp":1743659090551},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T00:00:00Z","timestamp":1102032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p>Nasal polyp tissue which contains mast cells and eosinophils is similar to the inflamed airway mucosa in cellular composition and mediator content. This investigation assessed the effect of desloratadine (DL), on activation of cells in nasal polyp tissue. Polyps were obtained from 22 patients with chronic rhinosinusitis [nine aspirin acetylosalitic acid (ASA)\u2010sensitive and 13 ASA\u2010tolerant]. Polyp tissue was dispersed by digestion, and preincubated with DL and incubated with anti\u2010immunoglobulin E (IgE) or calcium ionophore. LTC<jats:sub>4<\/jats:sub>, eosinophil cationic protein (ECP) and tryptase concentrations in supernatants were measured by immunoassays. Desloratadine (1, 10 and 50\u2003<jats:italic>\u03bc<\/jats:italic>M) inhibited calcium ionophore\u2010induced LTC<jats:sub>4<\/jats:sub> release by a mean of 29%, 50% and 63% respectively, and anti\u2010IgE\u2010induced LTC<jats:sub>4<\/jats:sub> release by a mean of 27%, 35% and 39% respectively. Calcium ionophore\u2010induced tryptase release was inhibited 60% and 69% by 10 and 50\u2003<jats:italic>\u03bc<\/jats:italic>M of DL, respectively, and anti\u2010IgE\u2010induced tryptase release was inhibited 33%, 47% and 66% for 1, 10 and 50\u2003<jats:italic>\u03bc<\/jats:italic>M of DL. Desloratadine 10\u2003<jats:italic>\u03bc<\/jats:italic>M and 50\u2003<jats:italic>\u03bc<\/jats:italic>M inhibited ECP release by and 45% and 48% respectively. Polyp tissue from ASA\u2010sensitive patients when compared with ASA\u2010tolerant patients released at baseline significantly more ECP (medians 120.0\u2003<jats:italic>\u03bc<\/jats:italic>g\/ml, range: 69.0\u2013182.0 <jats:italic>vs<\/jats:italic> 63.4\u2003<jats:italic>\u03bc<\/jats:italic>g\/ml, range: 3.7\u2013172.0; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), but similar amounts of tryptase and LTC<jats:sub>4<\/jats:sub>. This study demonstrated that DL inhibits activation of both eosinophils and mast cells derived from a site of airway mucosal inflammation.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2005.00642.x","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T09:27:17Z","timestamp":1102066037000},"page":"80-85","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of nasal polyp mast cell and eosinophil activation by desloratadine"],"prefix":"10.1111","volume":"60","author":[{"given":"M. L.","family":"Kowalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"DuBuske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,3]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00076.x"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00803.x"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.114239"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90478-2"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb00745.x"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90359-X"},{"key":"e_1_2_15_8_2","first-page":"S444","article-title":"Loratadine (L) reduces RANTES release by an epithelial cell line","volume":"99","author":"Lebel B","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1995.tb01133.x"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1997.tb01154.x"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90267-J"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70106-5"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.13508.x"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.suppl_2.S84"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023957"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1995.tb00257.x"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.116861"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(94)90130-9"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01130.x"},{"key":"e_1_2_15_20_2","first-page":"97","article-title":"Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells","volume":"52","author":"Kusters S","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01160.x"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.01088.x"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.23452.x"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1996.tb04622.x"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(03)01880-3"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70256-8"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199600521-00005"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.129123"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2005.00642.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2005.00642.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:45:20Z","timestamp":1697424320000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2005.00642.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1398-9995.2005.00642.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00642.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,3]]}}}